Combining nanotechnology with monoclonal antibody drugs for rheumatoid arthritis treatments.

Autor: Chi XK; College of Pharmacy, Jiamusi University, 258 Xuefu Road, Jiamusi, 154007, China.; Shulan International Medical College, Zhejiang Shuren University), 8 Shuren Street, Hangzhou, 310015, China.; Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, 866 Yu-Hang-Tang Road, Hangzhou, 310058, China., Xu XL; Shulan International Medical College, Zhejiang Shuren University), 8 Shuren Street, Hangzhou, 310015, China. ziyao1988@zju.edu.cn., Chen BY; Shulan International Medical College, Zhejiang Shuren University), 8 Shuren Street, Hangzhou, 310015, China., Su J; College of Pharmacy, Jiamusi University, 258 Xuefu Road, Jiamusi, 154007, China. sujin@jmsu.edu.cn., Du YZ; Institute of Pharmaceutics, College of Pharmaceutical Sciences, Zhejiang University, 866 Yu-Hang-Tang Road, Hangzhou, 310058, China. duyongzhong@zju.edu.cn.

Publikováno v: Journal of nanobiotechnology [J Nanobiotechnology] 2023 Mar 25; Vol. 21 (1), pp. 105. Date of Electronic Publication: 2023 Mar 25.